8-K
Current Report
PLIANT THERAPEUTICS, INC. Filed Acc 0001193125-25-109976
Exit or restructuring costs · Executive or director change
- Item 2.05 Costs associated with exit or disposal activities
- Item 5.02 Departure or appointment of directors or officers
From the SEC's structured data for this filing
Loading d949809d8k.htm…